Research articlePublished 6 May 2016
Hypoadiponectinemia: A link between visceral obesity and metabolic syndrome
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Metabolic syndrome (MetS) represents a combination of cardio-metabolic risk factors, including visceral obesity, glucose intolerance or type 2 diabetes, elevated triglycerides, reduced HDL cholesterol, and hypertension. MetS is rapidly increasing and prevalent worldwide as a consequence of the “epidemic” obesity, with a considerable impact on the global incidence of cardiovascular disease and type 2 diabetes. At present, some authors are disappointed on the role of insulin resistance as unifying factor in the occurrence of all the MetS components, whereas the role of visceral obesity is increasing. This review summarizes and critically evaluates the clinical and scientific evidence supporting the existence of MetS as a “fatal consequence of visceral obesity”. In view of this, the effects of some adipocytokines and other proinflammatory factors produced by fat accumulation on the occurrence of the MetS have been also emphasized. Accordingly, the “hypoadiponectinemia” has been proposed as the most interesting new hypothesis to explain the pathophysiology of MetS.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAfrican Journal of Medical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Rosario Scaglione”
- BylineArticles whose byline prints “Tiziana Di Chiara”
- BylineArticles whose byline prints “Christiano Argano”
- BylineArticles whose byline prints “Salvatore Corrao”
- BylineArticles whose byline prints “Giuseppe Licata”